API

A steroid is a type of organic compound that contains...

read more...

Pharma Intermediate

Pharmaceuticals refer to the drugs and medicines...

read more...

Speciality Chemicals

Specialty chemicals are those chemicals which is produced...

read more...

Products Under Devp.

New Products Under Development In response...

read more...

AARTI DRUGS LIMITED

AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER 2011
(` in Lakhs except for share data)
Particulars Quarter Ended Nine Months Ended Year ended
31st Dec 2011 30th Sept 11 31st Dec 2010 31st Dec 2011 31st Dec 2010 31st Mar 2011
Gross Sales / Income from Operations 16,394 15,348 14,604 47,431 38,012 52,301
Less : Excise Duty & Sales Tax 885 898 1,000 2,664 2,315 2,659
1. (a) Net Sales / Income from Operations 15,509 14,450 13,604 44,767 35,697 49,642
(b) Other Operating Income - - - - - -
2. Expenditure
(a). (Increase) / Decrease in stock in trade 353 (1,412) (707) (1,871) (1,971) (1,618)
(b). Consumption of raw materials 8,660 9,141 7,600 27,155 19,705 27,300
(c). Purchase of Traded Goods 1,669 2,113 2,621 5,562 6,572 8,421
(d). Employees cost 523 487 409 1,515 1,214 1,646
(e).  Depreciation 468 448 393 1,351 1,131 1,548
(f). Other expenditure 2,591 2,584 2,155 7,644 5,701 7,858
(g).Total Expenditure 14,264 13,361 12,471 41,356 32,352 45,155
3. Profit from Operations before Other Income 1,245 1,089 1,133 3,411 3,345 4,487
4. Other Income 3 2 2 9 7 8
5. Profit before Interest & Exceptional Items 1,248 1,091 1,135 3,420 3,352 4,495
6. Interest 574 440 377 1,432 939 1,348
7. Profit after Interest but before Exceptional Items 674 651 758 1,988 2,413 3,147
8. Exceptional Items - - - - -
9. Profit from Ordinary Activities before Tax 674 651 758 1,988 2,413 3,147
10.Tax Expenses  (Includes) 193 159 256 #REF! 795 #REF!
Provision for Taxation 118 119 184 400 586 650
Provision for Deferred Taxation 74 40 72 152 209 250
11.Net profit from ordinary Activities after Tax 481 493 502 #REF! 1,618 #REF!
12.Extraordinary Item (net of tax expenses ) - - - - - -
13.Net Profit for the period 481 493 502 #REF! 1,618 #REF!
14.Paid-up Equity Share Capital of `10/- each. 1,211 1,211 1,211 1,211 1,211 1,211
15. Reserves & Surplus (excluding revaluation reserves) - - - - - 14,441
16.Basic & Diluted E P S (in `) 3.97 4.07 4.14 #REF! 13.36 18.56
17.Public Shareholding
-Number of Shares 5469811 5493177 5638133 5469811 5638133 5569613
-Percentage of Total Shareholding 45.17 45.37 46.56 45.17 46.56 46.00
18.Promoters & Promoter Group
Shareholding
a) Pledged/Encumbered
- Number of Shares NIL NIL NIL NIL NIL NIL
-Percentage of shares( as a % of the NIL NIL NIL NIL NIL NIL
total shareholding of promoter and promoter group)
-Percentage of shares( as a % of the NIL NIL NIL NIL NIL NIL
total Share capital of the company)
b) Non-encumbered
- Number of Shares 6638739 6615373 6470417 6638739 6470417 6538937
-Percentage of shares( as a % of the total Shareholding 100 100 100 100 100 100
of promoter and promoter group)
-Percentage of shares( as a % of the total 54.83 54.63 53.44 54.83 53.44 54.00
Share capital of the company)
Notes :
1. The above results for the quarter and nine months ended 31st December,2011 have been reviewed by the Audit    Committee and approved by the Board of Directors in their Meeting held on 1st February,2012.
2. Company is operating as a Single Segment Company, engaged in Pharmaceuticals Business.
3. The Board of Directors have declared Interim Dividend of Rs   per equity share of Rs.10/- each    (   %) amounting to Rs.    and 7th February,2011 has been fixed as record date for the payment of the said
4. Figures for the previous period have been regrouped or rearranged wherever necessary.
5. Details of Investors Complaints received for the quarter ended 31st December, 2011   
Beginning:- 2               Received:- 0             Resolved:- 2       Pending:- 0
For and on behalf of the Board
For AARTI DRUGS LIMITED
Sd/-
Place : Mumbai MR. HARSHIT M. SAVLA
DATE   :1st February, 2012 (JT. MANAGING DIRECTOR)
 

Resource Download

Annual Report
Click here to download
annual report
Investor Presentation
Click here to download
Presentation

Copyright © 2010 Aarti Drugs Ltd. All Rights Reserved
Website Developed by : Sri Hema Infotech